Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078507 · ClinicalTrials.gov registry record · Phase 3
Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony
A Phase 3 study of Mandibular Advancement, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 3
- Development phase
- 186
- Enrollment target
- 2
- Study locations
NCT00078507: Completed Phase 3 study of Mandibular Advancement, sponsored by University of North Carolina, Chapel Hill.
NCT00078507 is a Phase 3 study of Mandibular Advancement that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 186 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078507, a Phase 3 study of Mandibular Advancement, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 186 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether facial exercises in conjunction with opening exercises routinely provided after facial surgery to correct a facial skeletal disharmony will shorten the time until a patient receives no unpleasant or negative facial sensation.
Conditions Studied
Interventions
- BEHAVIORAL Sensory Re-training
- BEHAVIORAL Sensory Retraining
- BEHAVIORAL Opening Exercises
Study Locations (2)
North Carolina
- School of Dentistry - Chapel Hill
- University Oral and Maxillofacial Surgery - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2001-12 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
What the finished NCT00078507 record still lists
NCT00078507 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Mandibular Advancement appearing as the primary indexed condition, and to 3 interventions - of which Sensory Re-training is the first listed.
NCT00078507 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00078507 about?
NCT00078507 is a clinical study titled "Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony". The purpose of this study is to determine whether facial exercises in conjunction with opening exercises routinely provided after facial surgery to correct a facial skeletal disharmony will shorten the time until a patient receives no unpleasant or negative facial sensation.
What is the current status of trial NCT00078507?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 186 participants. The study started on 2001-12. Estimated completion is 2007-03.
What conditions does trial NCT00078507 study?
This clinical trial studies the following conditions: Mandibular Advancement.
What interventions are being tested in trial NCT00078507?
The interventions under investigation include: Sensory Re-training (BEHAVIORAL), Sensory Retraining (BEHAVIORAL), Opening Exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT00078507?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078507 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00078507's enrollment target sits among peer trials
186 1412th of 2000 higher than 584 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia